AMETEK (NYSE:AME) Issues Q1 2026 Earnings Guidance

AMETEK (NYSE:AME) issued an update on its first quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.850-1.900 for the period, compared to the consensus earnings per share estimate of 1.900. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion. AMETEK also updated its FY 2026 guidance to 7.870-8.070 EPS.

AMETEK Trading Down 0.3%

Shares of AMETEK stock opened at $227.07 on Tuesday. AMETEK has a 1-year low of $145.02 and a 1-year high of $229.03. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.16 and a quick ratio of 0.72. The stock has a market cap of $52.27 billion, a P/E ratio of 36.17, a P/E/G ratio of 3.05 and a beta of 1.03. The stock’s 50 day simple moving average is $208.39 and its 200-day simple moving average is $194.48.

AMETEK (NYSE:AME) last announced its quarterly earnings data on Tuesday, February 3rd. The technology company reported $2.01 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.07. AMETEK had a return on equity of 16.66% and a net margin of 20.50%.The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.87 EPS. AMETEK has set its Q1 2026 guidance at 1.850-1.900 EPS and its FY 2026 guidance at 7.870-8.070 EPS. Analysts predict that AMETEK will post 7.15 EPS for the current fiscal year.

AMETEK Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Friday, December 5th were issued a dividend of $0.31 per share. The ex-dividend date was Friday, December 5th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.5%. AMETEK’s dividend payout ratio (DPR) is currently 19.56%.

Analysts Set New Price Targets

AME has been the topic of a number of recent analyst reports. Truist Financial upped their price objective on AMETEK from $219.00 to $229.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. DA Davidson increased their price target on AMETEK from $235.00 to $240.00 and gave the stock a “buy” rating in a report on Monday, December 8th. Deutsche Bank Aktiengesellschaft started coverage on shares of AMETEK in a report on Wednesday, January 21st. They issued a “buy” rating and a $271.00 price objective on the stock. Wall Street Zen raised shares of AMETEK from a “hold” rating to a “buy” rating in a research note on Saturday, November 1st. Finally, Oppenheimer downgraded shares of AMETEK from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 27th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $229.82.

Insider Buying and Selling

In other AMETEK news, VP Thomas M. Montgomery sold 6,388 shares of the stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $205.05, for a total transaction of $1,309,859.40. Following the sale, the vice president directly owned 22,116 shares in the company, valued at $4,534,885.80. This represents a 22.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO David A. Zapico sold 28,390 shares of the business’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $201.76, for a total transaction of $5,727,966.40. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 137,088 shares of company stock valued at $27,212,340 in the last ninety days. Company insiders own 0.57% of the company’s stock.

Key Stories Impacting AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Reported record fourth‑quarter and full‑year 2025 results, reinforcing underlying business strength. AMETEK Announces Record Fourth Quarter and Full Year Results
• Positive Sentiment: Completed acquisition of LKC Technologies (adds ophthalmic diagnostic capabilities), expanding AMETEK’s medical/diagnostics exposure and product portfolio. AMETEK Acquires LKC Technologies DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK
• Neutral Sentiment: Pre‑earnings coverage and previews highlight improving process markets and set context for investor expectations ahead of management commentary. Ametek Earnings on Deck as Process Markets Show Signs of Life Ametek Q4 2025 Earnings Preview
• Negative Sentiment: Updated FY‑2026 EPS guidance of $7.87–$8.07 is slightly below the consensus of $8.00, signaling more modest full‑year growth than investors expected.
• Negative Sentiment: Q1‑2026 EPS guidance of $1.85–$1.90 is at/just below the $1.90 consensus; revenue guidance centered around ~$1.9B also met modest expectations — collectively this conservative near‑term outlook is pressuring the stock.
• Negative Sentiment: Giverny Capital trimmed its AMETEK position, citing valuation, which is a small negative signal about investor positioning. Giverny Capital Asset Management Trimmed Ametek (AME) on Valuation

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. State Street Corp boosted its position in shares of AMETEK by 1.3% in the 3rd quarter. State Street Corp now owns 9,763,684 shares of the technology company’s stock valued at $1,835,573,000 after purchasing an additional 126,381 shares during the period. Invesco Ltd. grew its holdings in shares of AMETEK by 4.9% during the third quarter. Invesco Ltd. now owns 4,463,518 shares of the technology company’s stock worth $839,141,000 after buying an additional 209,043 shares during the last quarter. Lazard Asset Management LLC increased its holdings in shares of AMETEK by 35.7% in the third quarter. Lazard Asset Management LLC now owns 2,645,977 shares of the technology company’s stock valued at $497,444,000 after purchasing an additional 695,419 shares during the period. Northern Trust Corp raised its position in AMETEK by 0.4% during the 3rd quarter. Northern Trust Corp now owns 2,436,237 shares of the technology company’s stock worth $458,013,000 after buying an additional 10,510 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in shares of AMETEK by 37.8% in the 3rd quarter. AQR Capital Management LLC now owns 904,034 shares of the technology company’s stock worth $169,588,000 after acquiring an additional 247,922 shares during the period. Institutional investors and hedge funds own 87.43% of the company’s stock.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.